Paper Details

  1. Home
  2. Paper Details

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

Author: BarrettFrederick S, CosimanoMary P, DavisAlan K, FinanPatrick H, GriffithsRoland R, JohnsonMatthew W, MayDarrick G, SepedaNathan D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Major depressive disorder (MDD) is a significant health problem, and current treatments often have limited effectiveness and people don't always stick with them. New research suggests that one or two doses of psilocybin, a psychedelic drug, combined with therapy, may help reduce depression in people with cancer and those who haven't responded to other treatments.
Paper Details　
Original Abstract of the Article :
Major depressive disorder (MDD) is a substantial public health burden, but current treatments have limited effectiveness and adherence. Recent evidence suggests that 1 or 2 administrations of psilocybin with psychological support produces antidepressant effects in patients with cancer and in those w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643046/

データ提供：米国国立医学図書館（NLM）

Psilocybin-Assisted Therapy: A New Frontier in Depression Treatment

Major depressive disorder (MDD) is a debilitating illness with a significant impact on individuals and society. This study investigated the potential of psilocybin-assisted therapy, a novel approach involving the use of psilocybin, a psychedelic compound, in conjunction with psychological support, for treating MDD. The results suggest that psilocybin-assisted therapy could offer a promising new treatment option for individuals with MDD, particularly those who haven’t responded well to conventional therapies.

A New Horizon in Depression Treatment

This study explores a novel approach to depression treatment, one that challenges traditional methods. Psilocybin-assisted therapy represents a new frontier in mental health research, offering hope for individuals seeking alternative treatments. It’s like discovering a hidden oasis in the vast and arid landscape of depression research, a source of potential relief and renewal.

Understanding the Potential of Psychedelic Therapies

This study underscores the growing interest in psychedelic therapies. The findings suggest that psilocybin, under carefully controlled conditions and with appropriate support, could offer a valuable tool for treating MDD. It’s a reminder that even in the most challenging medical landscapes, there’s always the potential for new discoveries and treatments to emerge, offering hope for a brighter future.

Dr.Camel's Conclusion

This study offers a glimpse into a potential new approach to depression treatment. Psilocybin-assisted therapy represents a promising avenue for exploration, offering hope for individuals seeking alternative options. It's a reminder that the desert of mental health research is vast and full of potential, with new pathways and discoveries waiting to be uncovered.

Date :
  1. Date Completed 2022-01-17
  2. Date Revised 2022-01-17
Further Info :

Pubmed ID

33146667

DOI: Digital Object Identifier

PMC7643046

Related Literature

Article Analysis
・Effective treatment of depression
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.